Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03068923 · ClinicalTrials.gov registry record

Thrombosis Outcomes in Pediatric Venous Thromboembolism

A clinical trial of Venous Thromboembolism, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
120
Enrollment target
1
Study location

NCT03068923: Completed study of Venous Thromboembolism, sponsored by University of Texas Southwestern Medical Center.

NCT03068923 is a study of Venous Thromboembolism that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 120 participants, below the 6,293-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03068923, a study of Venous Thromboembolism, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

'The TOP Study' is a prospective cohort study whose main objective is to develop better prognostic biomarkers and identify children at risk of adverse thrombotic outcomes very early in the course after an initial venous thromboembolic events (VTE). The study will compare biomarkers in children that develop poor VTE outcomes (such as recurrence, postthrombotic syndrome and post PE impairment ) after an initial VTE with those that do not develop such outcomes.

Primary Outcome

PTS as assessed by the validated Manco-Johnson and the modified Villata PTS instruments determined a priori and confirmed by an endpoint adjudicating committee

Conditions Studied

Study Locations (1)

Texas

  • Children's Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2016-05
Est. Completion 2022-03-09

What the finished NCT03068923 record still lists

NCT03068923 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 6,293-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Venous Thromboembolism appearing as the primary indexed condition, and to 0 interventions.

NCT03068923 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03068923 about?

NCT03068923 is a clinical study titled "Thrombosis Outcomes in Pediatric Venous Thromboembolism". 'The TOP Study' is a prospective cohort study whose main objective is to develop better prognostic biomarkers and identify children at risk of adverse thrombotic outcomes very early in the course after an initial venous thromboembolic events (VTE). The study will compare biomarkers in children that ...

What is the current status of trial NCT03068923?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2016-05. Estimated completion is 2022-03-09.

What conditions does trial NCT03068923 study?

This clinical trial studies the following conditions: Venous Thromboembolism.

Who is sponsoring clinical trial NCT03068923?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03068923 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Thromboembolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03068923's enrollment target sits among peer trials

120 35th of 47 higher than 13 of 47 other Venous Thromboembolism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Venous Thromboembolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03068923, the US trial registry maintained by the National Library of Medicine. NCT03068923 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.